title: NE inhibits cerebrovascular mast cell exocytosis induced by cholinergic and peptidergic agonists.
abstract: Autonomic and sensory nerves frequently contact mast cells contained in rabbit leptomeningeal arteries. We have previously shown that parasympathetic and peptidergic neurotransmitters can stimulate mast cell granule exocytosis and serotonin (5-HT) release. In the present study, we examined ex vivo the possible action of the main sympathetic neurotransmitter, norepinephrine (NE), on this exocytotic process. NE, which had no effect on mast cell 5-HT content per se, totally inhibited carbachol-induced 5-HT release and partially reduced neuropeptide-induced 5-HT release. Pretreatment with the alpha 1-adrenergic blocker did not affect the inhibitory effect of NE. Pretreatment with specific beta 1- or beta 2-adrenergic blockers antagonized this action, but the beta 2-blocker exerts a more specific dose-dependent antagonism. Together with our previous data, these results indicate that the equilibrium between autonomic and sensory nerves may determine the release of 5-HT from mast cells (parasympathetic and sensory nerves can trigger exocytosis while the sympathetics can inhibit it). Such a mechanism could be implicated in pathophysiological events in which autonomic dysfunction is likely to be involved, such as vascular headache or other phenomena involving inflammation.
authors.affiliation: Laboratoire de Recherches Cérébrovasculaires, Centre National de la Recherche Scientifique (CNRS), Institut Fédératif de Recherches (IFR) 6, Université Paris VII, France.
authors.forename: A M
authors.initials: AM
authors.lastname: Reynier-Rebuffel
authors.forename: J
authors.initials: J
authors.lastname: Callebert
authors.forename: J M
authors.initials: JM
authors.lastname: Launay
authors.forename: J
authors.initials: J
authors.lastname: Seylaz
authors.forename: P
authors.initials: P
authors.lastname: Aubineau
mesh_terms: D018674:Adrenergic Antagonists / Q000494:pharmacology*; D000818:Animals; D001262:Atenolol / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002536:Cerebral Arteries / Q000187:drug effects / Q000502:physiology*; D002560:Cerebrovascular Circulation; D005089:Exocytosis / Q000187:drug effects*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology*; D011224:Prazosin / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism*; D013999:Timolol / Q000494:pharmacology
chemical_list: D018674:Adrenergic Antagonists; D012701:Serotonin; D001262:Atenolol; D013999:Timolol; D002217:Carbachol; D009638:Norepinephrine; D011224:Prazosin